Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Specialised Therapeutics Ltd,Nab-paclitaxel,"Metastatic breast cancer, contraindicated or intolerant to taxane chemotherapy",Nab-paclitaxel (Abraxane),Options for investment,Community and Hospital,
